{"name":"Keryx Biopharmaceuticals","slug":"keryx-biopharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":60641000,"revenueGrowth":224.6,"grossMargin":0,"rdSpend":37679000,"netIncome":-163440000,"cash":158872000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2017"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"KRX-0502","genericName":"KRX-0502","slug":"krx-0502","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"KRX-0502","genericName":"KRX-0502","slug":"krx-0502","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNbU1NR1JtUUZKdmo2RUhWV0c5OGVFSENrTmU2X3luemtRMHF0MmpDLV92MW5zYy1JUHBqbzd3NmJrUkxFWUxjYy1LcUh5NFU2cjlWX1VmZG1odWpILXRPYzFad056WDhEZkNVVlBPOWFHU3N0RlhFUk1ya3VIS1ZId0lCWEtqMmZNUVBQZGdwRElic3Qx?oc=5","date":"2025-12-15","type":"pipeline","source":"BioXconomy","summary":"Biotech Firms Announce Multiple CFO Changes - BioXconomy","headline":"Biotech Firms Announce Multiple CFO Changes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPWlV2b3NOalppYzZPUkR3TXVQRnFzaEtMV0hwekFOYTZGdDAwUlZULUtmZzY1UnlRU2Z4YkZTb3d1LWZSNU5ibmhOLU84a1JjemNSRC1oUzkxQkotbTNvSHFJR2tEa2YzNGpsR2NBN19KQVpXb0g0aTVWOExUdHpQY0w3RU9RcUgwcnpNWVF2NlQ3QV9LSkwzSG9odzFQQQ?oc=5","date":"2025-09-11","type":"pipeline","source":"Pharmafile","summary":"Brian Adams appointed as Kymera’s CLO and Corporate Secretary - Pharmafile","headline":"Brian Adams appointed as Kymera’s CLO and Corporate Secretary","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNN1NHNFU4anlkaEk3YmFYUW1HeUZZRFBFSUhHU3ItUEEtc0dsZnNadlVJb2tMMmJHZzU3SFk4YlZESTQxV1VSVzhSZk93RVZMTjhXNnYzbzRxMF8yeUtJZDdtM2p2bl81SFdrclA4bGdMNDRlUnVlVmhxWVhlT2NqcElENWVBS0E?oc=5","date":"2023-10-26","type":"pipeline","source":"Yahoo Finance","summary":"Iron Deficiency Anemia Market Size and Share to Grow by 2032, Predicts DelveInsight | Leading Companies Developing Therapies - Pharmacosmos, AMAG, Shield, Akebia, Keros, Keryx Biopharmaceuticals, Sier","headline":"Iron Deficiency Anemia Market Size and Share to Grow by 2032, Predicts DelveInsight | Leading Companies Developing Thera","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE5kc2ZiM0p5V1ZwbG41R3NocE04SnM4azZJMXJ1VTkzbEl0U3BQNGtGeExIYmxMc3hxTnJhczBMOE9qNThXU0ZoeElVbmVsal8wVmEtX05CdlM1N19fcG15dU1GMEowdw?oc=5","date":"2023-09-02","type":"pipeline","source":"Comparably","summary":"GSK vs UCB - Comparably","headline":"GSK vs UCB","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxPSDVteGl2Y09RaURnR0dRZndPa3V4RHVDdHNoTmZSc0REVzJBNDVhRHRMY0xpTkFKVnV5N0YwZEFsZDNWSDEteXhjOUdmR0J4d0ZEVlJwYWRfZVY5aDNxT1B2dnFNVTBDVnpSNy0wUHJmRDlGV2ZRdFFTeFJnUWpNbnd2TlhFUkd3U2hPd1M3akZDVVNyaFNzLTZGdnZwM3RhbzliSVhMN2hxTW5wNDhVT1VjSVBGUF9mVE92Y1dKai1BOEFhc0ZOUDBWNEdFckxVcDV5OWFxRm5KZnFwTTBpcWc1QzJWeWZPYTdSSk5vcmJzY3c?oc=5","date":"2019-02-05","type":"pipeline","source":"GlobeNewswire","summary":"Harrow Health Announces $11 Million Series A Financing for Melt Pharmaceuticals Subsidiary - GlobeNewswire","headline":"Harrow Health Announces $11 Million Series A Financing for Melt Pharmaceuticals Subsidiary","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPUGl5NERRRGljZ0tSSGVfMUowbVEwOG9KaVJXZHJ3elJHdDZSWllKSmQxbHV0dmNraVo0ZGUxR051SGpoVUJCSWlCbXBuWWRIWFZOYkxSUTNXclNkWllJa2k3OUg4RTlDcnBheXY5VW9ELVdicWNvQnJOeDc2bEVJLTFndzVwZzFXY0lpd1gtSUkxd3ZVTWJXbkNMZThkUGFsb3lNYVp3eDN0UDMzUVhXYXBNSzBpUQ?oc=5","date":"2018-11-15","type":"pipeline","source":"BioSpace","summary":"Akebia Therapeutics and Keryx Biopharmaceuticals Announce Chairperson for Combined Company - BioSpace","headline":"Akebia Therapeutics and Keryx Biopharmaceuticals Announce Chairperson for Combined Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQX29yTGt1SGJSY0hKNWs3NmpEMzdVV0s3WWc0bHAyWERONUVaQ1c2bm0xN0VxSEJzc1A0S29NZTNNd0lBRkNPaEhsVmxSZ0RyZ2hENkxTcnlWdXN5MmJ6cm9iZjVSdUl4Ri14REJOWnFvVTNWOWtpWGVZem5kbFJFVURfSklPNWJRcUVPZmFHdG5aZDBWNzVXdnRmVkY?oc=5","date":"2018-07-12","type":"pipeline","source":"Contract Pharma","summary":"Akebia Therapeutics & Keryx Biopharmaceuticals Merge - Contract Pharma","headline":"Akebia Therapeutics & Keryx Biopharmaceuticals Merge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNQjVSSlMwbGpmc3ZfdFpoaUV0Qll5ZTBrVWRSRzdGMDVqbmxpTmJ0SUpSMW5uWFBhaEszU2tSdU1reHRtekRLZzJNODA1Z0hJR1BaOWI5djNXUzlhNWZmc0ZxQm9zVHNJNGMwLWxhMF9SZWZOaGswdEltQWJJaUM5aC1CM2FZdGVyVVZjdFhycU9HWXlJX25sYkdjY3NNN3pN?oc=5","date":"2018-06-28","type":"pipeline","source":"BioPharma Dive","summary":"Akebia, Keryx to merge, creating $1B kidney disease company - BioPharma Dive","headline":"Akebia, Keryx to merge, creating $1B kidney disease company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPeFJQbDY1dXZHQWZuZEgxWFZlaEVLVXdvd2UxNnFVSjNHZVpVb0h3MmNPaG15ZURlZTZDVmhiV3NPZzZ5SGptVUJpdDRxd1dOa1h6REZ1MDI5TlZicTVCUWtwbHNZaktLVkV5M2pKU08xUUhVWWZiQmVfUkhSTy1kVVRRQ0Q0djBWUDJ0ZTdtRDNTUXlucFJTLTVYcjc4Y3FhdF8xR2dn?oc=5","date":"2017-12-14","type":"pipeline","source":"Contract Pharma","summary":"BioVectra, Keryx Enter Supply Agreement for Kidney Disease - Contract Pharma","headline":"BioVectra, Keryx Enter Supply Agreement for Kidney Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPOVB0N1ZheFZKWEdZdmR0M2Z1Y2VLMjdZMUtTM0RiZUFWMnNsT2h0bnlCdzlVUW5ibmdnZmJaZThvTlZkc3V5X0ZqNWg4bnF6RXRkd3otR1NmUFNrUXB6Uzkyc3NaUzNEWnIxYzU2R1N5LUxBQVFMLXpBMERZX2Y4ZGpocjF0QQ?oc=5","date":"2016-08-04","type":"pipeline","source":"BioPharma Dive","summary":"Keryx says Auryxia shortage ‘imminent’ - BioPharma Dive","headline":"Keryx says Auryxia shortage ‘imminent’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNRXFnUy1USXBTSXZOeGs2WmJ4bEpua3dhUlZXX2hOVzVBM0VFYWM4UGJqVkZjWGtZSnFZZkN2RDFZdWRTX3BKTW84WXVocXpDb0lOYU9MVkxSOUtZenY3QmVhMEltbnF5bmJpOWhUcHZTNC1CWnJaaFNzOE4wT0NwMi1Ba2dwRTVEdnlDa2RqY3N6UHROLUpnVjR1eG1femh3emFYXw?oc=5","date":"2016-08-02","type":"pipeline","source":"Fierce Pharma","summary":"Production glitch exhausts Keryx supply of kidney drug Auryxia - Fierce Pharma","headline":"Production glitch exhausts Keryx supply of kidney drug Auryxia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQWTBmMWs3WEZHMklhQ0Z3RjBkemtyUW5XT1dVdV9nSFZkOUI3aGhSVjB0aVc0NHhNdWlrUktMcHBCOHY1OVRBMGhjczMwLV9aTnJCVHYxdElOMnFMcWF5cjFQcV8xS1J2d3FKNTlkTHVlMXY0NlQxOVlLWkZDcWVzU0lCeEs4bWQxTlJ3NVdRSWg0UdIBlwFBVV95cUxPUmNqd2xVbkd5VlI2dzZvTG11Q2dOQk9CdnZTeUxBZWZEOENDYU9nTktPVUFnMDJndFBvYWd2VEZPekxPQ2sxVWtuSGI4dFR0TFJYUDByN2JDSVE4TUhMendBNFZIM0tWRTdDVHZjd2lyYzN5N0kyb1dyRktKS1htZG9nWGRqVnRwU1M1WlRDX1FFdmVQbmVJ?oc=5","date":"2016-01-05","type":"regulatory","source":"Fox Business","summary":"Keryx Biopharmaceuticals Grabs an Important Approval - Fox Business","headline":"Keryx Biopharmaceuticals Grabs an Important Approval","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":60641000,"revenuePeriod":"2017-12-31","revenueHistory":[{"value":60641000,"period":"2017-12-31"},{"value":18682000,"period":"2017-12-31"},{"value":14996000,"period":"2017-09-30"},{"value":15144000,"period":"2017-06-30"},{"value":11819000,"period":"2017-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":37679000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-163440000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":158872000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}